National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003

Preventing Chronic Disease

Volumn 5, Issue 3, 2008, Pages

  Ahmed, Faruque ^a   Perz, Joseph F ^a   Kwong, Sandy ^b   Jamison, Patricia M ^a   Friedman, Carol ^a   Bell, Beth P ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER REGISTRY; ETHNOLOGY; FEMALE; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; RACE; STATISTICS; TIME; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CONTINENTAL POPULATION GROUPS; FEMALE; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; SEER PROGRAM; TIME FACTORS; UNITED STATES;

EID: 84978414737     PISSN: 15451151     EISSN: 21665435     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006;118(12):3030-44.
2. Carriaga MT, Henson DE. Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 1995;75(1 Suppl):171-90.
3. Cancer facts and figures 2005. Atlanta (GA): American Cancer Society; 2005.
4. U.S. Cancer Statistics Working Group. United States cancer statistics: 2002 incidence and mortality web-based report version. Atlanta (GA): Centers for Disease Control and Prevention, and National Cancer Institute; 2005. http://www.cdc.gov/cancer/npcr/uscs. Accessed March 1, 2006.
5. El-Serag HB. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 2002;35(5 Suppl 2):S72-8.
6. Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2002. Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5, version 2.0. Lyon (FR): IARC Press; 2004.
7. Jemal A, Clegg LX, Ward E, Ries LA, Wu X, Jamison PM, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 2004;101(1):3-27.
8. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. [Published erratum in: Ann Intern Med 2004;140(2):151.] Ann Intern Med 2003;139(10):817-23.
9. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004;127(5 Suppl 1):S27-34.
10. Shea KA, Fleming LE, Wilkinson JD, Wohler-Torres B, McKinnon JA. Hepatocellular carcinoma incidence in Florida. Ethnic and racial distribution. Cancer 2001;91(5):1046-51.
11. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004;127(5 Suppl 1):S5-16.
12. North American Association of Central Cancer Registries. NAACCR guideline for enhancing Hispanic/Latino identification: revised NAACCR Hispanic/Latino identification algorithm [NHIA v2]. Springfield (IL): NAACCR Latino Research Workgroup; 2005. http://www.naaccr.org/filesystem/pdf/NHIA%20v2%2009-21-05.pdf. Accessed January 29, 2007.
13. International classification of diseases for oncology. 3rd ed. Geneva (CH): World Health Organization; 2000.
14. El-Serag HB, Davila JA. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A U.S. population-based study. Hepatology 2004;39(3):798-803.
15. Census regions and divisions of the United States. Washington (DC): U.S. Census Bureau. http://www.census.gov/geo/www/us_regdiv.pdf. Accessed March 7, 2008.
16. Code lists for place/country of birth: American Community Survey (ACS) 2000-U.S. states and countries 2006. Washington (DC): U.S. Census Bureau. http://www.census.gov/population/www/socdemo/foreign.html. Accessed March 1, 2006.
17. Kwong SL, Chen MS Jr, Snipes KP, Bal DG, Wright WE. Asian subgroups and cancer incidence and mortality rates in California. Cancer 2005;104(12 Suppl):2975-81.
18. Fay MP, Feuer EJ. Confidence intervals for directly standardized rates: a method based on the gamma distribution. Stat Med 1997;16(7):791-801.
19. Fay MP. Approximate confidence intervals for rate ratios from directly standardized rates with sparse data. Communications in Statistics: Theory and Methods 1999;28(9):2141-60.
20. Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariable methods. 2nd ed. Boston (MA): PWS-Kent; 1988.
21. Rosenblatt KA, Weiss NS, Schwartz SM. Liver cancer in Asian migrants to the United States and their descendants. Cancer Causes Control 1996;7(3):345-50.
22. Parker SL, Davis KJ, Wingo PA, Ries LA, Heath CW Jr. Cancer statistics by race and ethnicity. CA Cancer J Clin 1998;48(1):31-48.
23. Chang ET, Keegan TH, Gomez SL, Le GM, Clarke CA, So SK, et al. The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004. Cancer 2007;109(10):2100-8.
24. McCracken M, Olsen M, Chen MS Jr, Jemal A, Thun M, Cokkinides V, et al. Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. [Published erratum in: CA Cancer J Clin 2007;57(6):380.] CA Cancer J Clin 2007;57(4):190-205.
25. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006;28:112-25.
26. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. [Published errata in: MMWR Morb Mortal Wkly Rep 2006;55(6):158-9, MMWR Morb Mortal Wkly Rep 2007;56(48):1267.] MMWR Recomm Rep 2005;54(RR-16):1-31.
27. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004;127(5 Suppl 1):S35-50.
28. Di Bisceglie AM, Lyra AC, Schwartz M, Reddy RK, Martin P, Gores G, et al. Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol 2003;98(9):2060-3.
29. Chalasani N, Horlander JC Sr, Said A, Hoen H, Kopecky KK, Stockberger SM Jr, et al. Screening for hepatocellular carcinoma in patients with advanced cirrhosis. Am J Gastroenterol 1999;94(10):2988-93.
30. Hwang SJ, Tong MJ, Lai PP, Ko ES, Co RL, Chien D, et al. Evaluation of hepatitis B and C viral markers: clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the United States of America. J Gastroenterol Hepatol 1996;11(10):949-54.
31. Liang TJ, Heller T. Pathogenesis of hepatitis C-associated hepatocellular carcinoma. Gastroenterology 2004;127(5 Suppl 1):S62-71.
32. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006;144(10):705-14.
33. McQuillan GM, Coleman PJ, Kruszon-Moran D, Moyer LA, Lambert SB, Margolis HS. Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health 1999;89(1):14-8.
34. Armstrong GL, Alter MJ, McQuillan GM, Margolis HS. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology 2000;31(3):777-82.
35. Dienstag JL. Hepatitis C: a bitter harvest. Ann Intern Med 2006;144(10):770-1.
36. Clegg LX, Reichman ME, Hankey BF, Miller BA, Lin YD, Johnson NJ, et al. Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes Control 2007;18(2):177-87.
37. Hoofnagle JH. Hepatocellular carcinoma: summary and recommendations. Gastroenterology 2004;127(5 Suppl 1):S319-S323.
38. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997;336(26):1855-9.
39. Perz JF, Elm JL Jr, Fiore AE, Huggler JI, Kuhnert WL, Effler PV. Near elimination of hepatitis B virus infections among Hawaii elementary school children after universal infant hepatitis B vaccination. Pediatrics 2006;118(4):1403-8.
40. Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C. [Published erratum in: Hepatology 2004;40(1):269.] Hepatology 2004;39(4):1147-71.
41. Rugge JB, Lochner J, Judkins D. What is the best surveillance for hepatocellular carcinoma in chronic carriers of hepatitis B? J Fam Pract 2006;55(2):155-6.
42. Howe HL, Wu X, Ries LA, Cokkinides V, Ahmed F, Jemal A, et al. Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 2006;107(8):1711-42.